Template:C3 glomerulopathy: Difference between revisions

	C3 glomerulopathy Microchapters
Complement Mediated Glomerular Disorders Main Page
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating C3 glomerulopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasound
Other Imaging Studies
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
C3 glomerulopathy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of C3 glomerulopathy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on C3 glomerulopathy
CDC on C3 glomerulopathy
C3 glomerulopathy in the news
Blogs on C3 glomerulopathy
Directions to Hospitals Treating C3 glomerulopathy
Risk calculators and risk factors for C3 glomerulopathy

@@ Line 117: / Line 117: @@
 |- bgcolor="LightSkyBlue"
 !
-[[C3 glomerulopathy mammography|Mammography]]
+[[C3 glomerulopathy CT|CT]]
 |-
 !
@@ Line 142: / Line 142: @@
 !
 [[C3 glomerulopathy other diagnostic studies|Other Diagnostic Studies]]
-|-
-!
-|- bgcolor="LightSkyBlue"
-!
-[[C3 glomerulopathy biopsy|Biopsy]]
 |-
 !
@@ Line 159: / Line 153: @@
 |- bgcolor="PaleTurquoise"
 !
-[[C3 glomerulopathy chemotherapy|Chemotherapy]]
+[[C3 glomerulopathy Medical therapy|Medical Therapy]]
 |-
 !
@@ Line 171: / Line 165: @@
 |- bgcolor="PaleTurquoise"
 !
-[[Metastatic C3 glomerulopathy treatment|Metastatic C3 glomerulopathy]]
+[[C3 glomerulopathy primary prevention|Primary Prevention]]
-|-
-!
-|- bgcolor="PaleTurquoise"
-!
-[[C3 glomerulopathy bone metastasis|Bone Metastasis]]
 |-
 !
@@ Line 183: / Line 171: @@
 |- bgcolor="PaleTurquoise"
 !
-[[C3 glomerulopathy primary prevention|Primary Prevention]]
+[[C3 glomerulopathy secondary prevention|Secondary Prevention]]
 |-
 !

Revision as of 01:42, 11 November 2016